ERIKA GUIDER: Open Payments
NPI 1558638189 · LOVELAND, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 27 payments from 14 companies in 2025. Trend: 2023 $96 · 2024 $453 · 2025 $758
Food & beverage: $459Education: $299
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $220 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| ABBVIE INC. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Amgen Inc. | 3 | $54 |
| UCB, Inc. | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $36 |
| GENZYME CORPORATION | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Integra LifeSciences Corporation | 1 | $25 |
Products named: TREMFYA, DUPIXENT, Otezla, SKYRIZI, NEMLUVIO, Cimzia, Integra, Rhapsido.
Industry payments across CO — which companies pay providers there.
